The World Bank Report No: ISR16141 Implementation Status & Results Armenia Disease Prevention and Control Project (P128442) Public Disclosure Copy Operation Name: Disease Prevention and Control Project (P128442) Project Stage: Implementation Seq.No: 3 Status: ARCHIVED Archive Date: 18-Oct-2014 Country: Armenia Approval FY: 2013 Product Line: IBRD/IDA Region: EUROPE AND CENTRAL ASIA Lending Instrument: Specific Investment Loan Implementing Agency(ies): Ministry of Health, HSMP-PIU Key Dates Board Approval Date 27-Mar-2013 Original Closing Date 15-Dec-2019 Planned Mid Term Review Date 31-May-2017 Last Archived ISR Date 19-Apr-2014 Effectiveness Date 22-Jul-2013 Revised Closing Date 15-Dec-2019 Actual Mid Term Review Date Project Development Objectives Project Development Objective (from Project Appraisal Document) The Project development objective is to improve (i) Maternal and Child Health(MCH) services and the prevention, early detection, and management of selected Non- Communicable Diseases (NCD) at the Primary Health Care (PHC) level; and (ii) the efficiency and qualityof selected hospitals in Armenia. Has the Project Development Objective been changed since Board Approval of the Project? Yes No Component(s) Component Name Component Cost Performance-based incentives to improve MCH and NCD services in primary care fac 4.30 Hospital Modernization 38.90 Project Management 1.80 Overall Ratings Previous Rating Current Rating Public Disclosure Copy Progress towards achievement of PDO Satisfactory Satisfactory Overall Implementation Progress (IP) Satisfactory Satisfactory Overall Risk Rating Moderate Moderate Implementation Status Overview Implementation of Project activities is ongoing. The next implementation support visit is planned for end October/early November 2014. Locations No Location data has been entered Page 1 of 4 The World Bank Report No: ISR16141 Results Project Development Objective Indicators Public Disclosure Copy Indicator Name Core Unit of Measure Baseline Current End Target Percentage of antenatal care (ANC) attendees Percentage Value 0.00 90.00 screened for glycosuria, hypertension and Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 proteinuria in at least three antenatal visits Comments Percentage of population aged 40-74 screened Text Value a) 58.5%; b) 59.2% 70% for hypertension at least once in the last year a&b a) female; b) male Date 31-Dec-2011 19-Sep-2014 15-Dec-2019 Comments Percentage of population aged 40-74 screened Text Value a) 37%; b) 33.4% a) 60%; b) 57% for diabetes mellitus at PHC level at least once Date 31-Dec-2011 19-Sep-2014 15-Dec-2019 during the last 3 years a) female; b)male Comments Percentage of women aged 30-60 screened for Percentage Value 8.50 50.00 cervical cancer at least once during the last 3 Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 years and received the results Comments Bed occupancy rate at the new Medical Center Percentage Value 60.00 80.00 in Vanadzor Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 Comments Quality of care in a) MCH; and b) NCD Text Value a) 57%; b) 60% a) 63%; b) 66% provided by dotors measured by clinical Date 23-Jan-2013 19-Sep-2014 31-Dec-2018 vignettes Comments Intermediate Results Indicators Indicator Name Core Unit of Measure Baseline Current End Target % of PHC facilities in Group 1 of the study Percentage Value 0.00 100.00 Public Disclosure Copy receiving verifications of results, supervision Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 and feedbacks by SHA within two months after Comments the end of every semiannual period % of patient in the sample size receiving Percentage Value 0.00 100.00 independent verifications of results within two Date 23-Jan-2013 19-Sep-2014 31-Dec-2018 months after the end of every semiannual Comments period Page 2 of 4 The World Bank Report No: ISR16141 % of eligible PHC facilities receiving incentives Text Value 70 100 within two months after the end of every semi- Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 annual period Comments Public Disclosure Copy Level of awareness among adults in key NCD Text Value a) 66%; b) 32%; c) 49%; d) a) 95%; b) 65%; c) 80%; d) risk factors a) high blood pressure; b) high 58%; e) 49% 85%; e)80% cholesterol level; c) high salt intake; d) obesity; Date 24-Jan-2007 19-Sep-2014 15-Dec-2019 e) high glucose level Comments Health facilities constructed, renovated, and/or Number Value 83.00 equipped (number) Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 Comments Number of hospitals constructed/renovated Number Value 0.00 3.00 and/or equipped Date 23-Jan-2013 19-Sep-2014 31-Dec-2018 Comments % of pediatric patients newly diagnosed with Percentage Value 20.00 7.00 onco-hematology conditions by the Date 23-Jan-2013 06-Jan-2014 31-Dec-2018 Hematology Center who received treatment Comments overseas inthe past year Number of new clinical practice guidelines Number Value 0.00 10.00 developed for hospitals Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 Comments Annual (Cumulative) Number of hospital health workers receiving Number Value 0.00 300.00 training in a set of new clinical practice Date 23-Jan-2013 19-Sep-2014 15-Dec-2019 guidelines Comments % of public hospitals at marz level Percentage Value 5.00 90.00 implementing Quality Improvement Program Date 23-Jan-2013 19-Sep-2014 31-Dec-2018 Comments % of quarterly project progress reports Percentage Value 0.00 100.00 Public Disclosure Copy submitted on time Date 23-Jan-2013 19-Sep-2014 31-Dec-2018 Comments Data on Financial Performance (as of 11-Sep-2014) Financial Agreement(s) Key Dates Project Ln/Cr/Tf Status Approval Date Signing Date Effectiveness Date Original Closing Date Revised Closing Date P128442 IDA-52220 Effective 27-Mar-2013 17-May-2013 22-Jul-2013 15-Dec-2019 15-Dec-2019 Page 3 of 4 The World Bank Report No: ISR16141 Project Ln/Cr/Tf Status Approval Date Signing Date Effectiveness Date Original Closing Date Revised Closing Date P128442 TF-14138 Effective 11-Jul-2013 27-Sep-2013 27-Sep-2013 31-Dec-2018 31-Dec-2018 Disbursements (in Millions) Public Disclosure Copy Project Ln/Cr/Tf Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed P128442 IDA-52220 Effective USD 35.00 35.00 0.00 5.29 28.97 15.00 P128442 TF-14138 Effective USD 1.80 1.80 0.00 0.00 1.80 0.00 Disbursement Graph Key Decisions Regarding Implementation Not applicable Public Disclosure Copy Restructuring History There has been no restructuring to date. Related Projects There are no related projects. Page 4 of 4